1. The effects on glycerolipid synthesis of a series of compounds including many drugs were investigated in cell-free preparations and slices of rat liver. 2. p-Chlorobenzoate, p-chlorophenoxyisobutyrate, halofenate, D-amphetamine, adrenaline, procaine and N-[2-(4-chloro-3-sulphamoylbenzoyloxy)ethyl]norfenfluramine had little inhibitory effect on any of the systems investigated. 3. Two amphiphilic anions, clofenapate and 2-(pchlorophenyl)-2-(m-trifluoromethylphenoxy)acetate, both inhibited glycerol phosphate acyltransferase and diacylglycerol acyltransferase at approx. 1.6 and 0.7imM respectively. Clofenapate (1 mM) also inhibited the incorporation of glycerol into lipids by rat liver slices without altering the relative proportions of the different lipids synthesized. 4. The amphilic amines, mepyramine, fenfluramine, norfenfluramine, hydroxyethylnorfenfluramine, N-(2-benzoyloxyethyl)norfenfluramine, cinchocaine, chlorpromazine and demethylimipramine inhibited phosphatidate phosphohydrolase by 50 % at concentrations between 0.2 and 0.9mm. The last four compounds inhibited glycerol phosphate acyltransferase by 50% at concentrations between 1 and 2.6mm. None of the amines examined appeared to be aneffectiveinhibitor of diacylglycerol acyltransferase. 5. Norfenfluramine, hydroxyethylnorfenfluramine and N-(2-benzoyloxyethyl)norfenfluramino produced less inhibition of glycerol incorporation into total lipids than was observed with equimolar clofenapate. The major effect of these amines in liver slices was to inhibit triacylglycerol and phosphatidylcholine synthesis and to produce a marked accumulation of phosphatidate. 6. The results are discussed in terms of the control of glycerolipid synthesis. They partly explain the observed effects ofthe various drugs on lipid metabolism. The possible use of these compounds as biochemical tools with which to investigate the reactions of glycerolipid synthesis is considered.
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It has recently been shown that two classes ofdrugs, namely the derivatives of clofibrate (ethy 12-(4-chlorophenoxy)-2-methylpropionate] and fenfluramine (2-ethylamino-1-(m-trifluoromethylphenyl)-propane hydrochloride], inhibit glycerolipid synthesis in vitro. First, fenfluramine and its derivatives inhibit the synthesis of glycerides in preparations of rat and human liver (Marsh & Bizzi, 1972; Bowley et al., 1973) , rat intestine (Dannenburg et al., 1973) and human adipose tissue (Wilson & Galton, 1971) . There is also evidence to suggest that fenfluramine and N-(2-benzoyloxyethyl)norfenfluramine (S780, Servier Laboratories Ltd.) are hypolipidaemic agents (Duhault & Boulanger, 1965; Duhault & Malen, 1970; Rivilene, 1974) .
Secondly, p-chlorophenoxyisobutyrate inhibits the esterification of sn-glycerol 3-phosphate in cell-free preparations from rat liver (Scott & Hurley, 1969;  * N6e SAnchez. Vol. 148 Adams et al., 1971; Lamb & Fallon, 1972; Fallon et al., 1972) . Clofenapate [sodium 4-(4'-chlorophenyl)phenoxyisobutyrate] was more effective than p-chlorophenoxyisobutyrate in decreasing the concentrations of serum triacylglycerol (Craig, 1972) and in inhibiting glycerol phosphate esterification in homogenates of human liver and in mitochondrial and microsomal fractions of rat liver . In addition clofenapate was more potent in inhibiting the esterification of dihydroxyacetone phosphate than that of glycerol phosphate in rat liver mitochondrial fractions .
The present series of experiments was performed to investigate the relative abilities of compounds related to fenfluramine, halofenate and p-chlorophenoxyisobutyrate to inhibit glyceride synthesis in preparations from rat liver. Studies have shown that fenfluramine and some of its derivatives are effective inhibitors of phosphatidate phosphohydrolase (EC 3.1.3.4) (Brindley & Bowley, 1975). This observation was thought to be particularly significant since phosphatidate phosphohydrolase is at a branch point in glycerolipid synthesis and appears to have a regulatory function. In liver its activity is enhanced in conditions where there is an increased flux of fatty acids into glycerides (Vavrecka et al., 1969; Mangiapane et al., 1973; Lamb & Fallon, 1974) . In synaptosomal preparations the activity of phosphatidate phosphohydrolase is thought to be stimulated by acetylcholine (Yagihara et al., 1973; Schacht & Agranoff, 1973 leading to an enhanced incorporation of 32p into phosphatidate and phosphatidylinositol.
It also became evident from work with pig lymphocytes (Allan & Michell, 1975) that the effects of a wide variety of amphiphilic amines on glycerolipid synthesis could also be explained in terms of a decrease in the rate of conversion of phosphatidate into diacylglycerol. It was therefore decided to test whether compounds such as the local anaesthetics chlorpromazine, demethylimipramine and mepyramine might, in fact, directly inhibit phosphatidate phosphohydrolase.
Materials and Methods
Male Wistar rats (180-270g) were obtained from the Nottingham University Joint Animal Breeding Unit, Sutton Bonington, Leics., U.K. They were allowed free access to food and water before the experiments.
Materials
Unless stated to the contrary, cofactors, substrates and reagents were prepared or purchased as described previously (Sanchez et al., 1973; Mangiapane et al., 1973) . Adrenaline was purchased from Sigma (London) Chemical Co., Kingston-upon- Preparation of drug solutions. Unless stated to the contrary stock solutions of the drugs were adjusted to pH7 where necessary with NaOH and were stored at -20°C. Solutions of compounds S780, S1513 and adrenaline (2-33mM) were prepared immediately before use.
Fatty acid-poor bovine serum albumin (1 mg; Pentex Inc., Kankakee, Ill., U.S.A.) was added to each 4mg of compounds S780, S1204, adrenaline or halofenate to aid dispersion. The mixture was then sonicated at 21 KHz until a uniform emulsion was obtained.
Preparation of cell fractions. Cell fractions were prepared from rat liver essentially as described by Mangiapane et al. (1973) . However, the livers were perfused in situ with ice-cold 0.9% NaCl when the particle-free supematant was to be used as a source of enzyme. Protein concentrations were determined by a biuret method (Brindley & Hiibscher, 1965) .
Preparation ofmembrane-bound [3Hjphosphatidate.
The method was based on procedures described 1975 previously (Smith et al., 1967; Mitchell et al., 1971) .
[3H]Phosphatidate was synthesized on endoplasmic reticulum membranes which were obtained from rat liver. The incubation system used for this preparation contained, in a volume of 400ml, 16.6mm-potassium phosphate buffer (pH17.4), 1 mM-dithiothreitol, 50mM-NaF, 13.4nm-MgCI2, 8mM-ATP, 20m-rac-glycerol 3-phosphate, 25pum-CoA, 0.8m-potassium (3H]-palmitate (0.5#uCi/pumol; prepared by warming palmitic acid with a 20% molar excess of KOH), 3mg of fatty acid-poor bovine serum albumin/ml and 3mg of microsomal protein/ml. The incubation was for 30min at 370C. The reaction was stopped by adding sufficient icecold EDTA solution (adjusted to pH17.0 with KOH) to give a final concentration of 20mM. The mixture was frozen and stored overnight at -200C. After thawing it was sonicated at 0°C for 2min at 21 KHz and then layered over 0.3M-sucrose containing 1 mM-EDTA. The tubes were centrifuged for 80min at 4°C and 76000g (ray. = 7.62cm) and the pellets resuspended in about 35ml of 0.3M-sUcroSe.
Analysis of the 3H-labelled lipids from this preparation showed that approx. 97% of the radioactivity was in phosphatidate with the remainder in lysophosphatidate, diacylglycerol, unesterified fatty acid and triacylglycerol.
Methods
Determination of the rate ofglycerolipid synthesis from sn-glycerol 3-phosphate. The biosynthesis of glycerolipids was determined by measuring the rate of incorporation ofsn-[1,3-3H]glycerol 3-phosphate into lipids. The assay medium contained, in a volume of 0.25mn1, 25mM-Tris buffer (adjusted to pH17.4 with HCI), 5mM-dithiothreitol, 2.4mM-MgCl2, 3mM-ATP, 60pM-CoA, 0.8mM-potassium palmitate, 15.9mM-sn-[1,3-3H]glycerol 3-phosphate (0.5,0Ci/.umol) and 1.5mg of fatty acid-poor bovine serum albumin. Where indicated solutions of drugs were added to this medium. The reaction was started by the addition of rat liver homogenate (400,ug of protein). After 10min the reaction was stopped by the addition of 1.88ml of chloroform-methanol (1:2, v/v) and the lipids were extracted and anialysed as described elsewhere (Brindley, 1973) .
Measurement of phosphatidate phosphohydrolase activity. The enzyme was measured by following the synthesis of diacylglycerol from the membranebound [3H1]phosphatidate (Smith et al., 1967; Mitchell et al., 1971) . The assay system contained, in a volume of 0.25ml, 25mM-potassium phosphate buffer, pH 6.8, 6mg of fatty acid-poor bovine serum albumin/ml, ImM-MgCI2 and 25p1 of membranebound phosphatidate. Drugs were added as indicated and the reaction was started with particle-free supernatant (300,ug of protein) which contained Vol. 148 phosphatidate phosphohydrolase. The reaction was stopped after 20min at 370C by adding 1.88ml of chloroform-methanol (1:2, v/v). The phases were separated by adding 0.625ml of chloroform [containing 0.4 % (w/v) of olive oil as carrier] and 0.875 ml of water. After centrifugation and removal of the top phase, samples of the bottom phase were analysed for glycerides on columns of alumina (Mitchell et al., 1971) .
Measurement of diacylglycerol acyltransferase activity (EC 2.3.1.20). Diacylglycerol acyltransferase activity was measured by following the incorporation of radioactivity from [3H]palmitoyl-CoA into glycerides with 1,2-diacyl-sn-glycerol as an acyl acceptor. The assay system contained, in a final volume of 0.35ml, 25mM-Tris buffer (adjusted to pH7.4 with HCI), 5mM-dithiothreitol, 50,pM-[3H]-palmitoyl-CoA (2.6#uCi/4umol), 4mM-1,2-diacyl-snglycerol, 18mM-MgCl2 and 1.5mg of fatty acid-poor bovine serum albumin/ml. The diacylglycerol emulsion was prepared by pipetting a hexane solution of diacylglycerol into a tube, evaporating off the hexane under N2, adding the reagents described above and sonicating at 21 KHz until a uniform emulsion was obtained. The drug solutions were then added and the reaction was started by the addition of 70pg of microsomal protein. After shaking for 10min at 37°C the reaction was stopped with 1.88 mi of chloroform-methanol (1:2, v/v). The phases were separated by the addition of 0,625mi of chloroform and 0.775ml of water. After centrifuging, the bottom phase was washed once with 2ml of 50mM-Tris buffer (adjusted to pH8.0 with HCI), to remove unchanged palmitoyl-CoA. The glycerides were then purified by alumina chromatography (Mitchell et at., 1971 ).
Synthesis oflipidsfrom (1,3-3fIllgycerol by rat liver slices. The methods used have been described by Manning & Brindley (1972) . The reactions were stopped by rapid filtration under suction. The tissue was washed with approx. lSml of ice-cold 0.9% NaCl and placed in a weighed tube containing methanol-water (5:4, v/v). The weight of the tissue recovered was 100±10mg (S.D.). The slices were sonicated and the lipids extracted by the method of Hajra et al. (1968) . Water-soluble contaminants were removed by washing the extract two times with synthetic top phase. This was obtained by mixing 1litre of chloroform, 1litre of methanol, 4.00ml of water, 500ml of 2M-KCI-0.2M-H3PO4 and 40ml of conc. HCI and adding 4g of glycerol and 1 g of racglycerol 3-phosphate to the resulting top phase.
The radioactivity in the total lipids was determined directly by scintillation counting and lipid classes were analysed on t.l.c. plates of Kieselgel 60. The plates were developed for about 60% of their length with chloroform-methanol -acetic acidacetone-water (10:2:2:4:1, by vol.). After being dried the plates were then developed for their full length with hexane-diethyl ether-acetic acid (60:4: 1, by vol.) in order to achieve a separation of the various neutral lipid classes from the phospholipids. The lipids were detected with iodine vapour, scraped into counting vials, and their radioactivity was determined (Sanchez et al., 1973) .
Characterization of lipids. Lipids were identified by co-chromatography with authentic samples (Sanchez et al., 1973) . In addition, the phosphatidate synthesized in selected incubations with rat liver slices was characterized further. The lipids were analysed by two-dimensional chromatography on Kieselgel 60/Kieselgur F254 t.l.c. plates in the following solvent systems. The plates were developed in the first direction with chloroform-methanol-water-NH3 (sp.gr. 0.88) (24:14:1:2, by vol.) and in the second direction with the system described above for the one-dimensional chromatography. The distribution of radioactivity in lipids was the same in the one-and two-dimensional systems.
The area corresponding to phosphatidate was eluted from the gel with 4 x 5ml extractions of chloroform-methanol (1:1, v/v) and the solvent removed. To the residue were added 5,pmol of rac-glycerol 3-phosphate, 0.5 ml of methanoltoluene (1:1, v/v) and 0.5ml of methanolic 0.2M-KOH. The mixture was subjected to mild alkaline hydrolysis by leaving for 1 h at 0°C in order to obtain glycerol phosphate from phosphatidate. After the addition of 0.5ml of water the pH was adjusted to between 1 and 2 with Dowex 50 (H+ form). The aqueous phase was then washed with 2x2.5nml of diethyl ether. Samples of the aqueous extract were chromatographed in two dimensions on 0.6mm cellulose t.l.c. plates. The solvents were phenolsaturated water-acetic acid-ethanol (100:10:12, by vol.) in the first direction and methanol-98 % (v/v) formic acid-water (80:13:7, by vol.) in the second as recommended by Dawson (1963) . The percentage of the water-soluble radioactivity which migrated with glycerol phosphate was 88 % compared with authentic radioactive glycerol phosphate. This confirms that the original lipid was phosphatidic acid.
Samples of the total lipid fraction of control incubations and those to which drugs had been added were degraded by a more rigorous alkaline hydrolysis (Manning & Brindley, 1972) . More than 94% of the 3H was recovered in water-soluble compounds with the remainder almost equally distributed between non-saponifiable lipids and unesterified fatty acids. This indicated that the [1,3-3H]glycerol was incorporated almost exclusively into the glycerol backbone of the lipids.
Measurement of radioactivity. Radioactivity was determined by liquid-scintillation counting (Sanchez et al., 1973) .
Results
The first series of experiments involved measuring the effects ofa variety ofdrugs on the various stages of triacylglycerol synthesis in subcellular preparations from rat liver. In the first system rat liver homogenates were used to esterify sn-[1,3-3H]glycerol 3-phosphate with palmitate. The mean rate of glycerol phosphate incorporation into the total lipid fraction was 4.3±1.0 (S.D.) nmol/min per mg of protein [13 independent preparations (Brindley & Bowley, 1975) ]. Of the total lipid synthesized 14±5% (S.D.) was isolated as diacylglycerol and triacylglycerol. Most (about 83%) of the remainder was phosphatidate, which indicates that phosphatidate phosphohydrolase was rate-limiting in this system. The determination of the rate of glycerol phosphate incorporation into the total lipid fraction effectively measures the activity of glycerol phosphate acyltransferase, whereas the incorporation into glycerides indicates the relative activity of phosphatidate phosphohydrolase.
The activity of the soluble phosphatidate phosphohydrolase of rat liver was also assayed directly with membrane-bound [3H]phosphatidate as substrate.
This method is thought to determine the activity of the enzyme which participates in triacylglycerol synthesis (Hiibscher, 1970; Brindley, 1974) . The mean activity of this enzyme (nine preparations) was 0.9±0.5 (s.D.)nmol of glyceride formed/min per mg of supernatant protein.
Finally, diacylglycerol acyltransferase was assayed with the microsomal fraction of rat liver and an emulsion of 1,2-diacyl-sn-glycerol. Its mean activity from six preparations was 2.5±2.4 (S.D.) nmol of triacylglycerol synthesized/min per mg of microsomal protein.
The compounds which were tested in these systems will be divided into two groups, amphiphilic anions and amphiphilic cations. The results are summarized in Table 1 .
Effects ofamphiphilic anions p-Chlorophenoxyisobutyrate was not a good inhibitor of any of the systems tested but it was more potent than the related compound p-chlorobenzoate, which is not a hypolipidaemic agent. Clofenapate, a more hydrophobic derivative of p-chlorophenoxyisobutyrate, produced 50% inhibitions of glycerol phosphate incorporation into total lipids and into glycerides at concentrations of 1.6 and 0.7mM respectively (Table 1 ). This decreased rate of glyceride synthesis from glycerol phosphate does not appear to result from a direct inhibition of phosphatidate phosphohydrolase. When this enzyme was assayed directly a concentration of 6.8mM-clofenapate was required to produce a 50% inhibition and stimulations of up to 2-fold were obtained at 1-4mM-clofenapate. In addition, p-chlorobenzoate and p-chlorophenoxy- (6) n.m.
1.5 (4)* 3.2(6) 0.8 (6)t 0.9 (6)t -0.4 (6)t 0.5 (6)t 0.6 (6)t -10 (6)t 0.4 (4) 7 (4)* 0.2 (4) 0.3 (4) 0.7 (4) isobutyrate (3-20mM) stimulated the activity of the phosphohydrolase. Lower concentrations of clofenapate (0.1-0.4mM) also stimulated the activity of diacylglycerol acyltransferase by up to 2-fold. However, at a concentration of approx. 0.6mM clofenapate inhibited diacylglycerol acyltransferase activity by 50% (Table 1) .
Halofenate is also used as a hypolipidaemic agent but this compound had no inhibitory effect in any of the systems tested (Table 1) . However, in vivo it is rapidly metabolized to 2-(p-chlorophenyl)-2-(mtrifluoromethylphenoxy)acetic acid (Hucker et al., 1971) , and this compound closely resembled clofenapate in its inhibitory effects.
Effects ofamphiphilic amines
Of the amines examined adrenaline, procaine and compound S1204 had no inhibitory effects at the concentrations that were used ( Table 1 ). All of the other amines, except D-amphetamine, were effective inhibitors of phosphatidate phosphohydrolase in the range 0.2-0.9mM (Table 1) . They also inhibited the incorporation of glycerol phosphate into glycerides at similar concentrations.
None of the amines tested in the present study Vol. 148 appeared to be an effective inhibitor of diacylglycerol acyltransferase activity. Neither did fenfluramine, norfenfluramine, hydroxyethylnorfenfluramine and mepyramine inhibit glycerol phosphate acyltransferase activity except at relatively high concentrations (Table 1) .
In contrast, compounds S1513, S780, cinchocaine, chlorpromazine and demethylimipramine did inhibit glycerol phosphate acyltransferase activity by 50% at concentrations between 1 and 2.6mM.
Effects of clofenapate and some derivatives of fenfluramine on the incorporation of glycerol into lipids by rat liver slices
The synthesis of glycerolipids was determined by incubating rat liver slices with [1,3-3H] glycerol at a physiological concentration (0.1 mM) as described by Manning & Brindley (1972) . The time-course for this reaction is shown in Figs. I (a) and 1 (b) . The accumulation of [1,3-3H] (Liberti & Jezyk, 1970; Manning & Brindley, 1972) . The potential of the slices to synthesize glycerolipids is therefore only slightly less than the isolated cells. The rates obtained with the slices are also in the same range as those obtained by Kohout et al. (1971) who studied triacylglycerol accumulation with perfused liver. Although liver slices may not provide a good model system for studying some aspects of metabolism, they do provide a fairly active and reproducible system for studying the sites of action of various drugs which alter the rate of hepatic glycerolipid synthesis. In order to do this an incubation time of 20min was chosen, by which time phosphatidate and diacylglycerol had reached steadystate concentrations and the other lipids were being synthesized at constant rates (Figs. la and  lb) .
Treatment of the slices with up to 1 mM-clofenapate inhibited the incorporation of glycerol into the total lipid fraction. During this inhibition there was no significant change in the relative composition of the individual lipid classes (Fig. 2a) .
When the derivatives offenfluramine were added to liver slices there was much less inhibition of total lipid synthesis than was observed with the same concentrations of clofenapate (Fig. 2b) . The major effect of the fenfluramine derivatives was to alter the distribution of [1,3-3H]glycerol among the various lipid fractions. The compounds tested were N-(2-benzoyloxyethyl)norfenfluramine (S780 and S1513), and norfenfluramine and hydroxyethylnorfenfluramine, which are rapidly formed as metabolites of compounds S780 and S1513 (Beckett et al., 1972) .
Since the effects of these fenfluramine derivatives appeared to be identical, the results obtained with them have been averaged to produce Fig. 2(b) . This finding is different from that of Wilson & Galton (1971) , who showed that, compared with fenfluramine, 1975 were less than 10%X of the total incorporation and have been omitted from the Figure. The effects on total lipid synthesis of compounds S780, S1513, norfenfluramine and hydroxyethylnorfenfluramine (b) were obtained with seven, eight, three and three different preparations respectively, whereas the analyses of the different lipid classes were performed on three, four, three and three different preparations. Since these compounds appeared to produce the same effect, the results from them have been averaged.
compound S1513 had little effect on the synthesis of glycerides by intact adipocytes. From Fig. 2(b) it can be seen that the major effect of the fenfluramine derivatives was to decrease the synthesis of triacylglycerol and phosphatidylcholine, and to increase the accumulation of phosphatidate. There was no significant change in the steady-state concentration of labelled diacylglycerol.
Discussion
Of the anionic amphiphilic drugs, p-chlorophenoxyisobutyrate did inhibit glycerol phosphate acyltransferase as previously reported (Adams et al., 1971; Lamb & Fallon, 1972) , this compound might serve as a fairly selective inhibitor with which to investigate therelative activities ofthe glycerol phosphate and dihydroxyacetone phosphate pathways.
Recent experiments with isolated hepatocytes have shown that p-chlorophenoxyisobutyrate stimulates rather than inhibits the incorporation of glycerol and palmitate into glycerides (Capuzzi et al., 1974) . These results are consistent with the observations that the acyltransferases of glyceride synthesis are not inhibited until very high concentrations of p-chlorophenoxyisobutyrate ( Table 1 ), and that 3-20mM-p-chlorophenoxyisobutyrate stimulates phosphatidate phosphohydrolase activity. Capuzzi et al. (1974) conclude that p-chlorophenoxybutyrate could not lower plasma triacylglycerols by inhibiting hepatic lipid synthesis but this is contrary to the conclusions of Fallon et al. (1972) . Halofenate decreases the conversion of acetate into fatty acids and lipid by isolated rat hepatocytes and produces an equal decreasein all lipid classes (Horney & Margolis, 1974) . In the experiments performed with clofenapate no selective inhibition of lipid synthesis was observed (Fig. 2a) . (Fallon et al., 1972) and approx. 0.4mM for clofenapate (Thorp, 1970) (Thorp, 1970) and their ability to displace fatty acids from it, thus tending to increase fatty acid esterification and oxidation (Horney & Margolis, 1974) .
In contrast with the anionic compounds, the active amphiphilic cations inhibited phosphatidate phosphohydrolase at relatively low concentrations. Compounds S780, S1513, cinchocaine, chlorpromazine and demethylimipramine were also able to inhibit glycerol phosphate acyltransferase (Table 1) . The action of fenfluramine derivatives on the incorporation of glycerol into lipids by liver slices was compatible with an inhibition of glyceride and phospholipid synthesis at the level of phosphatidate phosphohydrolase: phosphatidate accumulated and the synthesis of triacylglycerol and phosphatidylcholine was depressed. However, the steady-state concentration of diacylglycerol was not significantly changed (Fig. 2b) . This might have resulted from a simultaneous decrease in the utilization of diacylglycerol. Dannenburg et al. (1973) demonstrated that fenfluramine inhibits acylglycerol palmitoyltransferase (EC 2.3.1.22) and we thought that diacylglycerol acyltransferase activity might also be inhibited. However, no evidence for a direct inhibition was obtained under the experimental conditions used. It is not known whether CDP-choline-1,2-diacyl-snglycerol cholinephosphotransferase (EC 2.7.8.2) might be inhibited by fenfluramine derivatives, although D-amphetamine has been postulated to have this effect (Hitzemann & Loh, 1973; Leonard & Neuhoff, 1974) . Another possibility is that the concentration of diacylglycerol has to reach a threshold before it can be metabolized further.
In the past there have been a number of reports about the effects of amphiphilic cations on phospholipid synthesis, the common feature of which is an increased labelling with 32p of phosphatidate or phosphatidylinositol. These effects, which have now been investigated further and which are discussed in greater detail elsewhere (Allan & Michell, 1975) , can also be explained in terms of an inhibition of phosphatidate phosphohydrolase. This results in an accumulation of phosphatidate which in some tissues leads to a redirection of glycerolipid synthesis into CDP-diacylglycerol, phosphatidylglycerol, diphosphatidylglycerol and phosphatidylinositol.
The mode of action of the amphiphilic cations on phosphatidate phosphohydrolase has not been fully investigated. However, it is likely that the inhibition is caused by a physical interaction between the cations and the phosphatidate resulting in the neutralization of the negatively charged phosphate group, which may be accompanied by the displacement of bivalent cations (Dawson & Hauser, 1970) . This view is supported by the following observations.
(1) The structure of the hydrophobic region of the amphiphilic amines seems to berelatively unimportant provided that it is bulky (Table 1) . (2) The amphiphilic anions are not good inhibitors of phosphatidate phosphohydrolase activity; in fact, at lower concentrations they all stimulate this activity. (3) The introduction of a polar group into compound S780 to yield compound S1204 removes the inhibitory effect (Table 1) . However, a direct comparison of the relative effectiveness of these compounds is made difficult because of their low solubilities at the concentrations used in the assay systems. (4) The concentration of chlorpromazine required to produce half-maximum synthesis of phosphatidylinositol in pig lymphocytes is sufficient to cause the neutralization of half of the acidic phospholipids in the assay system used (Allan & Michell, 1975) . It is thought that this stimulation of phosphatidylinositol synthesis results directly from the inhibition of phosphatidate phosphohydrolase activity.
The absolute concentration of the amphiphilic amines that is required to produce a 50 % inhibition of phosphatidate phosphohydrolase activity would therefore depend on the concentration of acidic phospholipids in a particular assay medium. Thus the values quoted in Table 1 should only be considered in terms of the relative inhibitory effects of the different amines. The amphiphilic amines are known to be concentrated in membranes. Local anaesthesia is obtained in frog sciatic-nerve membranes at concentrations of 6-16mmol of chlorpromazine or local anaesthetics per kg ofdry membranes. Approx. 5-10% of this concentration is required for general anaesthesia (Seeman, 1972) . In rats treated with 5mg of fenfluramine/kg of body weight, concentrations of 4080/8M-fenfluramine plus norfenfluramine can be detected in the whole liver (D. B. Campbell, personal communication) ; the concentration of these amines in the hepatocyte 1975 membranes would be even higher. The concentrations of the amphiphilic amines which inhibit phosphatidate phosphohydrolase (Table 1) are therefore reasonable in comparison with those expected in vivo. The ability of the amphiphilic amines to inhibit phosphatidate phosphohydrolase may be of importance in controlling glycerolipid synthesis, since this enzyme is thought to have a regulatory function in this process Mangiapane et al., 1973; Brindley, 1974; Lamb & Fallon, 1974) . The arguments presented in the present paper indicate that this inhibition can be obtained with a wide variety of cationic drugs in a number of tissues in vitro. However, the extent to which such an action might be responsible for their therapeutic actions or their side effects is unknown.
